Redmile Group, LLC Alpha Teknova, Inc. Transaction History

Redmile Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.29 - $2.81 $21,857 - $47,612	-16,944 Reduced 9.88%	154,509 $211,000
Q1 2024 May 15, 2024	BUY	$2.41 - $3.88 $25,179 - $40,538	10,448 Added 6.49%	171,453 $454,000
Q4 2023 Feb 14, 2024	SELL	$1.85 - $3.73 $273,516 - $551,469	-147,847 Reduced 47.87%	161,005 $600,000
Q2 2023 Aug 14, 2023	SELL	$1.8 - $3.98 $115,905 - $256,280	-64,392 Reduced 17.25%	308,852 $824,000
Q1 2023 May 15, 2023	SELL	$2.74 - $6.25 $506,502 - $1.16 Million	-184,855 Reduced 33.12%	373,244 $1.1 Million
Q3 2022 Nov 14, 2022	SELL	$3.34 - $9.2 $32,401 - $89,249	-9,701 Reduced 1.71%	558,099 $1.86 Million
Q1 2022 May 16, 2022	SELL	$12.79 - $21.64 $2.01 Million - $3.4 Million	-157,200 Reduced 21.68%	567,800 $7.84 Million
Q2 2021 Aug 16, 2021	BUY	$23.73 - $27.98 $17.2 Million - $20.3 Million	725,000 New	725,000 $17.2 Million

5.4M

Ticker TKNO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 28,080,500
Market Cap $217M
Description
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.